GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Apex Healthcare Bhd (XKLS:7090) » Definitions » Debt-to-EBITDA

Apex Healthcare Bhd (XKLS:7090) Debt-to-EBITDA : 0.07 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Apex Healthcare Bhd Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Apex Healthcare Bhd's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM3.1 Mil. Apex Healthcare Bhd's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was RM6.0 Mil. Apex Healthcare Bhd's annualized EBITDA for the quarter that ended in Mar. 2024 was RM125.3 Mil. Apex Healthcare Bhd's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was 0.07.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Apex Healthcare Bhd's Debt-to-EBITDA or its related term are showing as below:

XKLS:7090' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0   Med: 0.17   Max: 0.38
Current: 0.1

During the past 13 years, the highest Debt-to-EBITDA Ratio of Apex Healthcare Bhd was 0.38. The lowest was 0.00. And the median was 0.17.

XKLS:7090's Debt-to-EBITDA is ranked better than
90.67% of 75 companies
in the Medical Distribution industry
Industry Median: 2 vs XKLS:7090: 0.10

Apex Healthcare Bhd Debt-to-EBITDA Historical Data

The historical data trend for Apex Healthcare Bhd's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apex Healthcare Bhd Debt-to-EBITDA Chart

Apex Healthcare Bhd Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.36 0.32 0.23 0.12 0.02

Apex Healthcare Bhd Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.11 0.09 0.08 0.07

Competitive Comparison of Apex Healthcare Bhd's Debt-to-EBITDA

For the Medical Distribution subindustry, Apex Healthcare Bhd's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apex Healthcare Bhd's Debt-to-EBITDA Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Apex Healthcare Bhd's Debt-to-EBITDA falls into.



Apex Healthcare Bhd Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Apex Healthcare Bhd's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(4.593 + 5.938) / 441.94
=0.02

Apex Healthcare Bhd's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(3.148 + 5.993) / 125.284
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.


Apex Healthcare Bhd  (XKLS:7090) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Apex Healthcare Bhd Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Apex Healthcare Bhd's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Apex Healthcare Bhd (XKLS:7090) Business Description

Traded in Other Exchanges
N/A
Address
1-5 Jalan TTC 1, Cheng Industrial Estate, Melaka, MLA, MYS, 75250
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing and marketing of pharmaceutical products; Wholesale and distribution of pharmaceutical and healthcare products; and Corporate comprising investments, properties, and others.

Apex Healthcare Bhd (XKLS:7090) Headlines

No Headlines